Astrotech Announces Closing of $37.3 Million Bought Deal Offering of Common Stock and Full Exercise of Option to Purchase Additional Shares

The gross proceeds to the Company from the offering were approximately $37.3 million, before deducting underwriting discounts and commissions and offering expenses payable by Astrotech.\nH.C.

Metadata
Provider: 
Business Wire, Inc.Business Wire, Inc.
Retrieved on: 
Monday, April 12, 2021
Information
Tags: 
Hardware, Electronic design automation, Semiconductor, Security, Manufacturing, Technology, Other Technology, Other Manufacturing, Science, Telecommunications, Software, Networks, Other Science, Engineering, Research, Initial public offering, U.S. Securities and Exchange Commission, Financial markets, Prospectus, Registration statement, Stock market, Finance, Forward-looking statement, Financial economics, Underwriting, Red herring prospectus
Geotags: 
Texas, United States, NEW YORK
⚠generated by AI ↴
Summary
Key Points: 
  • The gross proceeds to the Company from the offering were approximately $37.3 million, before deducting underwriting discounts and commissions and offering expenses payable by Astrotech.\nH.C.
  • 333-253835) filed with the Securities and Exchange Commission (SEC) and declared effective on March 15, 2021 and the accompanying prospectus contained therein.
  • The offering of the securities was made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement.
  • The Company assumes no obligation to update these forward-looking statements.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210412005951/en/\n'


Astrotech Corporation (NASDAQ: ASTC), announced today the closing of its previously announced underwritten public offering of 24,885,828 shares of its common stock, which included 3,245,977 shares sold pursuant to the full exercise of the underwriter’s option to purchase additional shares, at a price to the public of $1.50 per share, less underwriting discounts and commissions. The gross proceeds to the Company from the offering were approximately $37.3 million, before deducting underwriting discounts and commissions and offering expenses payable by Astrotech.

H.C. Wainwright & Co. acted as the sole book-running manager for the offering.

Astrotech intends to use the net proceeds of the offering for general corporate purposes, working capital, and capital expenditures.

The securities described above were offered by the Company pursuant to a "shelf" registration statement on Form S-3 (File No. 333-253835) filed with the Securities and Exchange Commission (SEC) and declared effective on March 15, 2021 and the accompanying prospectus contained therein. The offering of the securities was made only by means of a prospectus, including a prospectus supplement, forming a part of the effective registration statement. A final prospectus supplement and the accompanying prospectus relating to this offering were filed with the SEC and are available on the SEC’s website at www.sec.gov. Electronic copies of the final prospectus supplement and the accompanying prospectus relating to this offering may also be obtained by contacting H.C. Wainwright & Co., LLC at 430 Park Avenue, 3rd Floor, New York, NY 10022, by e-mail at [email protected] or by calling (212) 856-5711.

This announcement is neither an offer to sell, nor a solicitation of an offer to buy, any of these securities and shall not constitute an offer, solicitation or sale in any state or jurisdiction in which such offer, solicitation, or sale is unlawful. Any offer, if at all, will be made only by means of the prospectus forming a part of the effective registration statement.

About Astrotech Corporation

​Astrotech (NASDAQ: ASTC) is a science and technology development and commercialization company that launches, manages, and builds scalable companies based on innovative technology in order to maximize shareholder value. Astrotech is headquartered in Austin, Texas. For information, please visit www.astrotechcorp.com.

This press release contains forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995, including regarding the anticipated use of proceeds from the offering. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These factors include, but are not limited to: the intended use of net proceeds from the public offering, the Company’s ability to obtain additional financing, the severity and duration of the COVID-19 pandemic and its impact on the U.S. and worldwide economy, the timing, scope and effect of further U.S. and international governmental, regulatory, fiscal, monetary and public health responses to the COVID-19 pandemic, whether we can successfully complete the development of our new products and proprietary technologies, whether we can obtain the FDA and other regulatory approvals required to market our products under development in the United States or abroad, and whether the market will accept our products and services, market and other conditions, as well as other risk factors and business considerations described in the Company’s Securities and Exchange Commission filings including our annual report on Form 10-K. Any forward-looking statements in this document should be evaluated in light of these important risk factors. In addition, any forward-looking statements included in this press release represent the Company’s views only as of the date of its publication and should not be relied upon as representing its views as of any subsequent date. The Company assumes no obligation to update these forward-looking statements.

Copyright: 
Copyright Business Wire 2021